Skip to content
OpenCapital
Get started

Progyny PGNY Enterprise value

Enterprise value at other companies

CVS Health logo
CVS HealthCVS
$96.84B+4.3%
UnitedHealth Group logo
UnitedHealth GroupUNH
$295.52B-44.2%
Natera, Inc. logo
Natera, Inc.NTRA
$27.5B+49.9%
Pediatrix Medical Group logo
Pediatrix Medical GroupMD
$2.2B+22.3%
Organon logo
OrganonOGN
$9.01B-26.4%
BillionToOne, Inc. logo
BillionToOne, Inc. BLLN
$3.24B—

Other financials

Income statement

See full
Revenue$328.5M+1.4%
Gross profit$83.1M+9.6%
Operating income$35.4M+46.4%
Net income$24.2M+60.9%
EPS (diluted)$0.29+70.6%

Balance sheet

See full
Cash & equivalents$131.6M+20.5%
Total debt$27.3M-5.6%
Total equity$439.3M-6.0%
Total assets$698.3M-4.4%

Cash flow

See full
Operating cash flow$45.9M-7.7%
CapEx$6.3M+123%
Free cash flow$39.6M-15.7%

Valuation

See full
Market cap$2.09B-27.1%
P/E30.8×-23.7×
P/S1.6×-0.7×

Profitability

See full
Gross margin24.1%+2.1pp
Operating margin7.5%+1.4pp
Net margin5.2%+0.9pp
FCF margin14.3%-1.9pp

Returns & leverage

See full
Return on equity14.9%+4.8pp
Debt / equity0.1×0.0×
Current ratio2.1×-0.3×

Where this comes from

Calculated from Progyny’s reported figures.

$1.4Bmarket cap+$27.3Mtotal debt−$131.6Mcash and equivalents=$1.29B

The official record: Progyny’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Progyny's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Progyny's enterprise value?
Progyny (PGNY) reported enterprise value of $1.29B in Q1 2026.
How has Progyny's enterprise value changed year-over-year?
Progyny's enterprise value decreased by 29.6% year-over-year, from $1.83B to $1.29B.
What is the long-term trend for Progyny's enterprise value?
Over 5 years (2020 to 2025), Progyny's enterprise value has grown at a -10.8% compound annual growth rate (CAGR), from $3.77B to $2.13B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.